Tahoe Forest Cancer Center

Information may not be reliable

Cancer Center - Clinical Services

Emergency Medical Services
Insurance & Billing

We Offer Free Supportive Care

Introduction to Cancer Treatment

Questions to Ask
A Word about Clinical Trials
Getting a Second Opinion

General Cancer Information

Stem Cell Transplantation
Side Effects of Cancer Treatment
Complementary and Alternative

Diagnostics & Monitoring Tests

Complementary Alternative Medicine

Lung Cancer - Non-Small Cell
Lung Cancer - Small Cell

What Are Clinical Trials?
Phases of Clinical Trials
How are Clinical Trials Conducted?
Clinical Trial Safeguards
Participating in Clinical Trials
The Cost of Clinical Trials
Finding Specific Clinical Trials
The Future of Clinical Trials
Clinical Trial Database

Hints for Patients and Friends

Birth Control and Sexuality
Home Health Care
Financial and Insurance Issues

Creating the National Model for Rural Healthcare Delivery
The Tahoe Forest Cancer Center, located in Truckee California, is committed to providing the highest quality cancer treatment and care to our patients. Led by Medical Director Laurence Heifetz, MD, FACP and Medical Oncologist Hematologist Ahrin Koppel, MD, the mission of Tahoe Forest Cancer Center is to provide the highest quality cancer treatment and care to patients, using the most appropriate and current cancer therapies available in an honest, supportive, compassionate and respectful manner.

Latest Cancer News

Panobinostat Promising in Relapsed/Refractory Hodgkins Lymphoma (11-9-2010)
An ongoing study of the experimental drug panobinostat (LBH-589) reports promising activity in heavily pretreated patients with relapsed and refractory Hodgkins lymphoma (HL). These findings were presented... Continue Reading
New Bladder-preserving Therapy Promising in Bladder Cancer (11-9-2010)
A new bladder-preserving approach to treatment of locally invasive bladder cancer appears promising, both for patients for whom radical cystectomy is indicated and for those previously ineligible for curative... Continue Reading
Study Takes Closer Look at Erbitux Efficacy in Patients with Specific KRAS Mutations (11-8-2010)
Although colorectal cancer patients with mutations in the KRAS gene tend not to respond to drugs such as Erbitux (cetuximab), responsiveness may vary by the specific type of KRAS mutation. These results... Continue Reading

Types of Cancer

Tahoe Forest Cancer Center
10956 Donner Pass Road, Suite 210